Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2014
Total Assets: $220.3M
Liabilities Breakdown FY2014
Total Liabilities: $13.5M
Asset Breakdown
Total Assets: $220.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $150.6M | 68.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.8M | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $67.0M | 30.4% |
Liabilities Breakdown
Total Liabilities: $13.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.3M | 46.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.3M | 53.6% |